Skip to content

Randomized Multicenter Trial of Prehospital Initiated Facilitated Percutaneous Coronary Intervention (PCI) Versus Primary PCI in ST-segment-Elevation MI (STEMI)

Randomized, Controlled Multicenter Trial of Prehospital Initiated Facilitated PCI Versus Primary PCI in Patients With STEMI LIPSIA-STEMI Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00359918
Acronym
LIPSIA STEMI
Enrollment
162
Registered
2006-08-03
Start date
2006-08-31
Completion date
2009-08-31
Last updated
2018-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction

Keywords

infarction, facilitated PCI, primary PCI, infarct size, fibrinolysis, ST-elevation myocardial infarction (STEMI)

Brief summary

Prehospital initiated facilitation of primary percutaneous coronary intervention by fibrinolysis might be helpful in re-opening the infarct related artery prior to percutaneous coronary intervention. This studies tests the hypothesis that prehospital initiated facilitated PCI is superior to primary percutaneous coronary intervention with respect to infarct size.

Detailed description

Patients with STEMI with symptoms \< 3 hours are randomized in the region of Leipzig to either prehospital full-dose fibrinolysis (+ASA, Clopidogrel and heparin) with subsequent facilitated percutaneous coronary intervention or to primary percutaneous coronary intervention (after ASA + heparin + clopidogrel). Patients undergo cardiac magnetic resonance for assessment of infarct size early at day 1-4 after randomization.

Interventions

Primary PCI

PROCEDUREPrimary PCI

Primary PCI

Sponsors

Holger Thiele
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Angina pectoris \< 3 hours * ST-elevation myocardial infarction

Exclusion criteria

* Active bleeding * Active gastric ulcus * Previous stroke * Uncontrolled hypertension (\> 200 mmHg) * Cerebral surgery \< 8 weeks * Major surgery \< 4 weeks * Malignancy * Treatment with coumarines * Pregnancy

Design outcomes

Primary

MeasureTime frame
Infarct size and microvascular obstruction assessed by MRI1-6 days

Secondary

MeasureTime frame
Clinical endpoints (bleeding, death, Re-MI, stroke)30 days
ST-segment resolution90 min

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 29, 2026